Join
Live feed
·
PRReleasevia Quantisnow
Cerevel Therapeutics Holdings Inc. logo

Cerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results

ByQuantisnow·Wall Street's wire, on your screen.
CERE· Cerevel Therapeutics Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CERE (Cerevel Therapeutics Holdings Inc.) and more on Quantisnow.